Personal information

Verified email addresses

Verified email domains

Inmunohemathology, Apheresis and Celular Therapy, Quality Management, Patient Safety, Mieloproliferative diseases
Spain

Biography

- Bachelor of Medicine from the University of Navarra (1996) and Specialist in Hematology and Hemotherapy (2001).
- In 2008 I did a master's degree in Transfusion Medicine and Cell Therapy from the UAB
- Doctor of Medicine "cum laude" from the University of Navarra (February-2016).
- Master's degree in Hematopoietic Transplantation from the University of Valencia.
- University Expert in Organization and Management of Health Services from the UPNA.
- University Expert in Clinical Management from UNIR.
- I have developed my activity within the Hospital Complex of Navarra with different administrative responsibilities (including head of section and head of service between 2014 and 2017).
- My healthcare and research activity has been focused for 20 years on Hemotherapy, cell therapy, quality management systems and patient safety.
- Responsible for Hemovigilance of the Hospital Transfusion Service and secretary of the Hospital Transfusion Committee for more than 10 years.
- Responsible for the Quality Management System of the Hemotherapy Unit of the Hospital Complex of Navarra from 2010 to 2016. During this period I have been able to become extensively familiar with the ISO 9001 standards. Thanks to this experience, I currently advise other Services of the Navarre Universitary Hospital (HUN) that want to obtain this quality certification.
- I collaborate with the Navarrabiomed Hematology research group and have participated in several clinical trials in the field of hematopoietic neoplasms and in the emerging patient safety group (which is developing a safety project with the funding of a grant FIS).
- I maintain my post-doctoral teaching activity associated with the UPNA.
- Developed activity in the field of patient management and safety as a member of the Support Service for Clinical Management and Care Continuity of the Navarra Hospital Complex since December 2019. Part of the Safety Commission and the group of managers of the CHN SiNASP since 2013.
- Currently is Quality Manager on the Tissue and Blood Bank of Navarre (Banco de Sangre y Tejidos de Navarra) since november 2022

Activities

Employment (2)

Universidad Publica de Navarra: Pamplona, Navarra, ES

2022-08-28 to present | Profesor Contratado Doctor - Grado de Medicina (Asignatura de Hematología) (Ciencias de la Salud)
Employment
Source: Self-asserted source
Antelo ML

Servicio Navarro de Salud: Pamplona, Navarra, ES

1997-05-14 to present | PhMD (Haematology)
Employment
Source: Self-asserted source
Antelo ML

Education and qualifications (6)

Agencia Nacional de Evaluación de la Calidad y Acreditación: Madrid, ES

2021-02 to present | Profesor Contratado Doctor
Qualification
Source: Self-asserted source
Antelo ML

Universidad Politécnica de Cataluña: Barcelona, Cataluña, ES

2018 to 2019 | Experto Universitario en "Patient Blood Management" (Medicina)
Qualification
Source: Self-asserted source
Antelo ML

Universidad Publica de Navarra: Pamplona, Navarra, ES

2017 to 2018 | Experto Universitario en Organización y Gestión de Servicios Sanitarios
Qualification
Source: Self-asserted source
Antelo ML

Universidad de Valencia Departament Medicina Preventiva i Salut Pública Ciències de l'Alimentació Toxicologia i Medicina Legal: Valencia, Comunidad Valenciana, ES

2017 to 2018 | Máster en Trasplante de Progenitores Hematopoyéticos
Qualification
Source: Self-asserted source
Antelo ML

Universidad de Navarra: Pamplona, Navarra, ES

2013 to 2016-03-16 | Doctor
Qualification
Source: Self-asserted source
Antelo ML

Universidad Autónoma de Barcelona Departamento de Biología Celular Fisiología e Immunología: Barcelona, Catalunya, ES

2007-10 to 2008 | Máster en Medicina Transfusional y Terapia Celular
Qualification
Source: Self-asserted source
Antelo ML

Professional activities (4)

Banco de Sangre y Tejidos de Navarra: Pamplona, Navarra, ES

2022-10-05 to present | Responable de Calidad del Banco de Sangre y Tejidos de Navarra (Servicio Navarro de Salud-Osasunbidea)
Service
Source: Self-asserted source
Antelo ML

Complejo Hospitalario de Navarra: Pamplona, ES

2019-11-18 to 2022-10-01 (Apoyo a la Gestión Clínica y Continuidad Asistencial)
Service
Source: Self-asserted source
Antelo ML

Hospital Universitario de Navarra: Pamplona, Navarra, ES

2014-02-10 to 2018-10-15 | Jefe de Sección (Hematología)
Service
Source: Self-asserted source
Antelo ML

Fundación Pedro Barrié de la Maza: A Coruna, Galicia, ES

1990 | Beca de estudios universitarios
Distinction
Source: Self-asserted source
Antelo ML

Works (22)

Manejo de la anemia periquirúrgica en cirugía electiva.Conclusiones y recomendaciones según metodología Delphi-UCLA

Revista Española de Anestesiología y Reanimación
2023-12 | Journal article
Contributors: Antelo ML
Source: Self-asserted source
Antelo ML

PBM: Now more than ever necessary,PBM: Ahora más que nunca es necesario

Revista Espanola de Anestesiologia y Reanimacion
2021 | Journal article
EID:

2-s2.0-85115635313

Part of ISSN: 00349356
Contributors: García-Erce, J.A.; Jericó, C.; Abad-Motos, A.; Rodríguez García, J.; Antelo Caamaño, M.L.; Domingo Morera, J.M.; Sola Lapeña, C.; Arroyo, J.L.; Fernández Fuertes, F.; Zalba Marcos, S. et al.
Source: Self-asserted source
Antelo ML via Scopus - Elsevier

Preoperative hemogram as a predictive factor for iron deficit and/or transfusion in patients scheduled for arthroplasty,El hemograma como factor predictivo de déficit de hierro y/o transfusión en paciente pendiente de artroplastia

Revista Espanola de Anestesiologia y Reanimacion
2021 | Journal article
EID:

2-s2.0-85111018441

Part of ISSN: 00349356
Contributors: Zalba Marcos, S.; Galbete, A.; Urrechaga Igartua, E.; Antelo Caamaño, M.L.; Cerdán, G.; García Erce, J.A.
Source: Self-asserted source
Antelo ML via Scopus - Elsevier

Reply,Respuesta

Medicina Clinica
2021 | Journal article
EID:

2-s2.0-85113608919

Part of ISSN: 15788989 00257753
Contributors: Zalba Marcos, S.; Antelo Caamaño, M.L.; García-Erce, J.A.
Source: Self-asserted source
Antelo ML via Scopus - Elsevier

Engraftment after autologous hematopoietic stem cell transplantation in patients mobilized with Plerixafor: A retrospective, multicenter study of a large series of patients

Transfusion and Apheresis Science
2021-06 | Journal article
Contributors: M. Luisa Antelo; Ane Altuna; J. José Gimeno; J. Javier Ferreiro; Cristina Amunárriz; J. José Mateos; Saioa Zalba; Aitziber Alkorta; José Rifón; J. Luis Arroyo et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.

Journal of clinical apheresis
2021-03-29 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Patients and relatives as auditors of safe practices in oncology and hematology day hospitals.

BMC health services research
2021-01-07 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy.

Journal of the National Cancer Institute
2020-08-08 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group.

Medicina clinica
2020-07-09 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Effect of the application of the "Patient blood management" programme on the approach to elective hip and knee arthroplasties.

Medicina clinica
2020-05-28 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 3)‎

Do Patients and Relatives Have Different Dispositions When Challenging Healthcare Professionals About Patient Safety? Results Before and After an Educational Program.

Journal of patient safety
2020-03-23 | Journal article
Source: Self-asserted source
Antelo ML

Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis.

Medicina clinica
2020-01-21 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Transfusion of D positive red cells to selected D-negative patients.

Medicina clinica
2019-11-29 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document.

Bone marrow transplantation
2019-11-06 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 3)‎

Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies.

Journal of medical genetics
2019-10-05 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.

Annals of surgical oncology
2019-06-17 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide.

Expert review of hematology
2015-09-14 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Evaluation of the post-transfusion platelet increment and safety of riboflavin-based pathogen reduction technology (PRT) treated platelet products stored in platelet additive solution for 5 days or less versus 6-7 days.

Transfusion and Apheresis Science
2015-08-28 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Mobilization of hematopoietic progenitor cells from allogeneic healthy donors using a new biosimilar G-CSF (Zarzio®).

Journal of clinical apheresis
2015-05-23 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.

Annals of hematology
2014-07-02 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide.

Annals of hematology
2013-01-26 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎

Improved traceability and transfusion safety with a new portable computerised system in a hospital with intermediate transfusion activity.

Blood transfusion = Trasfusione del sangue
2011-01-17 | Journal article
Source: Self-asserted source
Antelo ML
grade
Preferred source (of 2)‎